These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 32793446)
1. The Current Evidence on Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma. Oh D; Kim JH Korean J Thorac Cardiovasc Surg; 2020 Aug; 53(4):160-167. PubMed ID: 32793446 [TBL] [Abstract][Full Text] [Related]
2. [Neoadjuvant chemoradiotherapy or chemotherapy for locally advanced esophageal cancer?]. Babic B; Fuchs HF; Bruns CJ Chirurg; 2020 May; 91(5):379-383. PubMed ID: 32140748 [TBL] [Abstract][Full Text] [Related]
3. [The role of neoadjuvant therapy in multimodality treatment of locally advanced esophageal squamous cell carcinoma: perspective from the NEOCRTEC5010 trial]. Guo XF; Fang WT Zhonghua Wai Ke Za Zhi; 2021 Aug; 59(8):646-650. PubMed ID: 34192855 [TBL] [Abstract][Full Text] [Related]
4. CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT Tang H; Tan L; Shen Y; Wang H; Lin M; Feng M; Xu S; Guo W; Qian C; Liu T; Zeng Z; Hou Y; Yu Z; Jiang H; Li Z; Chen C; Lian C; Du M; Li H; Xie D; Yin J; Zhao N; Wang Q BMC Cancer; 2017 Jun; 17(1):450. PubMed ID: 28659128 [TBL] [Abstract][Full Text] [Related]
5. Effects of neoadjuvant radiochemotherapy on pathological staging and prognosis for locally advanced esophageal squamous cell carcinoma. Cao XF; He XT; Ji L; Xiao J; Lv J Dis Esophagus; 2009; 22(6):477-81. PubMed ID: 19703071 [TBL] [Abstract][Full Text] [Related]
6. A retrospective comparison of neoadjuvant chemoradiotherapy regimens for locally advanced esophageal cancer. Sanford NN; Catalano PJ; Enzinger PC; King BL; Bueno R; Martin NE; Hong TS; Wo JY; Mamon HJ Dis Esophagus; 2017 Jul; 30(7):1-8. PubMed ID: 28475728 [TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant treatment for esophageal squamous cell carcinoma. Baba Y; Watanabe M; Yoshida N; Baba H World J Gastrointest Oncol; 2014 May; 6(5):121-8. PubMed ID: 24834142 [TBL] [Abstract][Full Text] [Related]
8. The current evidence in support of multimodal treatment of locally advanced, potentially resectable esophageal cancer. Zacherl J Dig Dis; 2014; 32(1-2):171-5. PubMed ID: 24603404 [TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemotherapy or chemoradiotherapy for locally advanced esophageal cancer. Smithers BM; Thomson I Thorac Surg Clin; 2013 Nov; 23(4):509-23. PubMed ID: 24199701 [TBL] [Abstract][Full Text] [Related]
10. Combined Modality Therapy for Management of Esophageal Cancer: Current Approach Based on Experiences from East and West. Moaven O; Wang TN Surg Clin North Am; 2019 Jun; 99(3):479-499. PubMed ID: 31047037 [TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemoradiotherapy or chemotherapy? A comprehensive systematic review and meta-analysis of the options for neoadjuvant therapy for treating oesophageal cancer. Deng HY; Wang WP; Wang YC; Hu WP; Ni PZ; Lin YD; Chen LQ Eur J Cardiothorac Surg; 2017 Mar; 51(3):421-431. PubMed ID: 27694253 [TBL] [Abstract][Full Text] [Related]
13. Chemotherapy and novel targeted therapies for operable esophageal and gastroesophageal junctional cancer. van den Ende T; Smyth E; Hulshof MCCM; van Laarhoven HWM Best Pract Res Clin Gastroenterol; 2018; 36-37():45-52. PubMed ID: 30551856 [TBL] [Abstract][Full Text] [Related]
15. Analysis of patients scheduled for neoadjuvant therapy followed by surgery for esophageal cancer, who never made it to esophagectomy. Depypere L; Thomas M; Moons J; Coosemans W; Lerut T; Prenen H; Haustermans K; Van Veer H; Nafteux P World J Surg Oncol; 2019 May; 17(1):89. PubMed ID: 31133018 [TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or the gastroesophageal junction: A meta-analysis based on clinical trials. Zhao X; Ren Y; Hu Y; Cui N; Wang X; Cui Y PLoS One; 2018; 13(8):e0202185. PubMed ID: 30138325 [TBL] [Abstract][Full Text] [Related]
17. Overview of different available chemotherapy regimens combined with radiotherapy for the neoadjuvant and definitive treatment of esophageal cancer. Tomasello G; Ghidini M; Barni S; Passalacqua R; Petrelli F Expert Rev Clin Pharmacol; 2017 Jun; 10(6):649-660. PubMed ID: 28349718 [TBL] [Abstract][Full Text] [Related]
18. Preoperative chemoradiation with paclitaxel-carboplatin or with fluorouracil-oxaliplatin-folinic acid (FOLFOX) for resectable esophageal and junctional cancer: the PROTECT-1402, randomized phase 2 trial. Messager M; Mirabel X; Tresch E; Paumier A; Vendrely V; Dahan L; Glehen O; Vasseur F; Lacornerie T; Piessen G; El Hajbi F; Robb WB; Clisant S; Kramar A; Mariette C; Adenis A BMC Cancer; 2016 May; 16():318. PubMed ID: 27194176 [TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant treatments for locally advanced, resectable esophageal cancer: A network meta-analysis. Chan KKW; Saluja R; Delos Santos K; Lien K; Shah K; Cramarossa G; Zhu X; Wong RKS Int J Cancer; 2018 Jul; 143(2):430-437. PubMed ID: 29441562 [TBL] [Abstract][Full Text] [Related]